103 related articles for article (PubMed ID: 2985949)
1. Effects of tunicamycin on the expression of beta-adrenergic receptors in human astrocytoma cells during growth and recovery from agonist-induced down-regulation.
Doss RC; Kramarcy NR; Harden TK; Perkins JP
Mol Pharmacol; 1985 May; 27(5):507-16. PubMed ID: 2985949
[TBL] [Abstract][Full Text] [Related]
2. Use of a density shift method to assess beta-adrenergic receptor synthesis during recovery from catecholamine-induced down-regulation in human astrocytoma cells.
Waldo GL; Doss RC; Perkins JP; Harden TK
Mol Pharmacol; 1984 Nov; 26(3):424-9. PubMed ID: 6092895
[TBL] [Abstract][Full Text] [Related]
3. Beta adrenergic receptor repopulation of C6 glioma cells after irreversible blockade and down regulation.
Homburger V; Pantaloni C; Lucas M; Gozlan H; Bockaert J
J Cell Physiol; 1984 Dec; 121(3):589-97. PubMed ID: 6094600
[TBL] [Abstract][Full Text] [Related]
4. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
Neve KA; Molinoff PB
Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
[TBL] [Abstract][Full Text] [Related]
5. Regulation of beta-adrenergic receptors during exposure of astrocytoma cells to catecholamines.
Perkins JP; Toews ML; Harden TK
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():37-46. PubMed ID: 6145327
[TBL] [Abstract][Full Text] [Related]
6. Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1.
Hughes RJ; Insel PA
Mol Pharmacol; 1986 Jun; 29(6):521-30. PubMed ID: 3012317
[TBL] [Abstract][Full Text] [Related]
7. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
Zaremba TG; Fishman PH
Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
[TBL] [Abstract][Full Text] [Related]
8. Effects of IL-1 and cortisol on beta-adrenergic receptors, cell proliferation, and differentiation in cultured human A549 lung tumor cells.
Nakane T; Szentendrei T; Stern L; Virmani M; Seely J; Kunos G
J Immunol; 1990 Jul; 145(1):260-6. PubMed ID: 2162889
[TBL] [Abstract][Full Text] [Related]
9. Evidence for cell type dependent mechanisms in agonist-induced down-regulation of beta-adrenoceptors.
Rademaker B; Kramer K; Bast A; Timmerman H
Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):321-36. PubMed ID: 1971452
[TBL] [Abstract][Full Text] [Related]
10. Characterization of agonist-induced beta-adrenergic receptor-specific desensitization in C62B glioma cells.
Frederich RC; Waldo GL; Harden TK; Perkins JP
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):103-18. PubMed ID: 6315795
[TBL] [Abstract][Full Text] [Related]
11. Regulation of adenosine 3':5'-monophosphate content of human astrocytoma cells: desensitization to catecholamines and prostaglandins.
Su YF; Cubeddu L; Perkins JP
J Cyclic Nucleotide Res; 1976 Jul-AUG; 2(4):257-70. PubMed ID: 184125
[TBL] [Abstract][Full Text] [Related]
12. The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells.
Morin MJ; Porter CW; McKernan P; Bernacki RJ
J Cell Physiol; 1983 Feb; 114(2):162-72. PubMed ID: 6822608
[TBL] [Abstract][Full Text] [Related]
13. Cellular redistribution of beta-adrenergic receptors in a human astrocytoma cell line: a comparison with the epidermal growth factor receptor in murine fibroblasts.
Wakshull E; Hertel C; O'Keefe EJ; Perkins JP
J Cell Biochem; 1985; 29(2):127-41. PubMed ID: 2999168
[TBL] [Abstract][Full Text] [Related]
14. Recovery of beta-adrenergic receptors following long term exposure of astrocytoma cells to catecholamine. Role of protein synthesis.
Doss RC; Perkins JP; Harden TK
J Biol Chem; 1981 Dec; 256(23):12281-6. PubMed ID: 6271779
[TBL] [Abstract][Full Text] [Related]
15. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
Irimura T; Gonzalez R; Nicolson GL
Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
[TBL] [Abstract][Full Text] [Related]
16. A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta 1- and beta 2-adrenergic receptors.
Snavely MD; Ziegler MG; Insel PA
Mol Pharmacol; 1985 Jan; 27(1):19-26. PubMed ID: 2981399
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid regulation of beta-adrenergic receptors in 3T3-L1 preadipocytes.
Nakada MT; Stadel JM; Poksay KS; Crooke ST
Mol Pharmacol; 1987 Apr; 31(4):377-84. PubMed ID: 3033466
[TBL] [Abstract][Full Text] [Related]
18. Zilpaterol hydrochloride alters abundance of β-adrenergic receptors in bovine muscle cells but has little effect on de novo fatty acid biosynthesis in bovine subcutaneous adipose tissue explants.
Miller EK; Chung KY; Hutcheson JP; Yates DA; Smith SB; Johnson BJ
J Anim Sci; 2012 Apr; 90(4):1317-27. PubMed ID: 22079997
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of translation and glycosylation of pituitary glycoproteins.
Pérez GT; Apfelbaum ME
Acta Physiol Pharmacol Ther Latinoam; 1996; 46(2):127-37. PubMed ID: 8998367
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
Meeker RB; Harden TK
Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
